Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic Acid vs Estradiol in Vulvovaginal Atrophy
NCT06144814Completed
- Sponsor
- Koru Health
- Start
- Apr 2023
- Primary completion
- Sep 2023
- Modality
- Hydrogel Systems
- Countries
- 1
01
Overview
Randomised, open-label trial of hyaluronic acid sodium composite gel for injection in Vulvovaginal atrophy (VVA) (2 arms), sponsored by Koru Health. Primary endpoint: Vaginal Health Index at 1 month. Started Apr 2023; status: completed.
02
Drugs
hyaluronic acid sodium composite gel for injection
03
Conditions
Vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT06144814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06144814.